Skip to Content
Merck

Key Documents

View All Documentation

940739

TissueFab® PODS Growth Factor Loaded Bioink Kit

Vascularization, Vis/405nm

Sign In to View Organizational & Contract Pricing.

Select a Size

Change View
Technical Service
Need help? Our team of experienced scientists is here for you.
Let Us Assist

description

applications: cell proliferation, cell culture, tissue engineering

sterility

(Endotoxin: <50 EU/ml), (Bioburden (Total Aerobic): <5 CFU/ml), (Bioburden (fungal): < 5 CFU/mL)

form

viscous liquid (or gel)

composition

PODS Human IGF-1, 25µg , PODS Human PDGF-BB, 25µg , PODS Human TNF alpha, 25µg , PODS Human VEGF-165, 25µg , TissueFab bioink, (Gel)MA Vis/405 nm, low endotoxin

impurities

Bioburden (Total Aerobic): <5 CFU/ml, Bioburden (fungal): < 5 CFU/mL, Endotoxin: <50 EU/ml

color

colorless to pale yellow

pH

6.5-7.5

compatibility

(extrusion-based 3D bioprinting)

storage temp.

−20°C

General description

Rethink your bioinks with TissueFab®


About the material:


The TissueFab® PODS Growth Factor Loaded Bioink Kit, vascularization, Vis/405 nm contain:


  • Low endotoxin conductive bioink containing visible light photoinitiator
  • Human TNF alpha PODS®
  • Human VEGF-165 PODS®
  • Human IGF-1 PODS®
Printing and crosslinking parameters:

  • Suitable for extrusion-based bioprinting
  • Visible light crosslinking at 405 nm wavelength

TissueFab PODS Growth Factor Loaded Bioink kit, vascularization, Vis/405nm is a ready-to-use, GelMA based bioink kit which is formulated for high cell viability, printing fidelity, and is designed for extrusion-based 3D bioprinting and subsequent crosslinking with exposure to 405nm visible light. TissueFab PODS Growth Factor Loaded Bioink kit, vascularization, GelMA Vis/405nm can be used with most extrusion-based bioprinters, is biodegradable and cytocompatible.


Included growth facors, TNF alpha, VEGF-165, and IGF-1 are known to play crucial roles in promoting vasculogenesis and angiogenesis. Their inclusion with PODS delivery system allows their sustained release within bioprinted constructs and retainment of 70% bioactivity after 6 months. When mixed with the bioink component, the included PODS growth factors can promote angiogenesis.


More information and a step by step protocol can be found under the "More Documents" section of this page.

Application

TissueFab PODS Growth Factor Loaded Bioink kit, vascularization, Vis/405nm enables the precise fabrication of 3D cell models and tissue constructs for research in 3D cell biology, tissue engineering, in vitro tissue models, and regenerative medicine.

Features and Benefits

Key Features and Benefits:


Each TissueFab® bioink is developed and tested to meet strict criteria to best suit researchers′ needs. This includes:
  • Printability and rheological properties
  • Crosslinking
  • Cell viability
  • Biocompatibility
  • Low bioburden
  • Low endotoxin

This product contains 10 ml of bioink solution and growth factors PODS® packaged separately to allow for optimization.

Legal Information

TISSUEFAB is a registered trademark of Merck KGaA, Darmstadt, Germany
PODS is a registered trademark of Cell Guidance Systems Ltd

Still not finding the right product?

Explore all of our products under TissueFab® PODS Growth Factor Loaded Bioink Kit

Kit Components Also Available Separately

Product No.
Description
SDS & Pricing
  • 918741
    TissueFab® bioink  , (Gel)ma -VIS/405nm, low endotoxin
    SDS
  • 939226
    Protein delivery system, Human TGF-α, PODS®
    SDS
  • 939285
    Protein delivery system, Human VEGF-165, PODS®
    SDS
  • 938076
    Protein delivery system, Human IGF-1, PODS®
    SDS

Storage Class

10 - Combustible liquids

wgk

WGK 3

Choose from one of the most recent versions:

Certificates of Analysis (COA)

Lot/Batch Number

It looks like we've run into a problem, but you can still download Certificates of Analysis from our Documents section.

If you need assistance, please contact Customer Support

Already Own This Product?

Find documentation for the products that you have recently purchased in the Document Library.

Visit the Document Library